Common Contracts
4 similar Consulting Agreement contracts by Pluristem Therapeutics Inc, Pluri Inc.
Consulting AgreementConsulting Agreement • February 13th, 2023 • Pluri Inc. • Biological products, (no disgnostic substances)
This Consulting Agreement (the “Agreement”) is entered into as of January 1st 2023 (the “Effective Date”) by and between Pluri Biotech Ltd., with its principal place of business at MATAM Park, Building 5, Haifa 31905 Israel (“Company”), and Mr. Zalman (Zami) Aberman, Israeli ID# 26014043 from Tel Mond, Israel (“Consultant”).
Consulting AgreementConsulting Agreement • January 3rd, 2022 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Consulting Agreement (the “Agreement”) is entered into as of January 1st 2022 (the “Effective Date”) by and between Pluristem Ltd., with its principal place of business at MATAM Park, Building 5, Haifa 31905 Israel (“Company”), and Mr. Zalman (Zami) Aberman, Israeli ID# 26014043 from Tel Mond, Israel (“Consultant”).
Amended and Restated Consulting AgreementConsulting Agreement • September 10th, 2020 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Consulting Agreement (this “Agreement”) is entered into as of September 10, 2020 (the “Effective Date”) by and between Pluristem Ltd., with its principal place of business at MATAM Park, Building 5, Haifa 31905 Israel (“Company”), and Rose High Tech Ltd. of Tel Mond, Israel (“Consulting Company”).
Consulting AgreementConsulting Agreement • September 12th, 2018 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This Consulting Agreement (this “Agreement”) is entered into as of September, 12, 2018 (the “Effective Date”) by and between Pluristem Ltd., with its principal place of business at MATAM Park, Building 5, Haifa 31905 Israel (“Company”), and Rose High Tech Ltd. of Tel Mond, Israel (“Consulting Company”).
